alzhub.org
Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

Home › Research › Clinical trials

Clinical trials

Every Alzheimer's trial in our copy of the ClinicalTrials.gov registry — completed, running and abandoned. Filter it, then follow the link to the official record.

If you are thinking about joining a trial

A listing here is a record that a study was registered. It is not a recommendation, and it does not mean the study is still recruiting or that anyone is eligible. Registry entries go stale.

Talk to the treating doctor first, then contact the study team listed on the official ClinicalTrials.gov record. The NIA's free referral line can help you look: 1-800-438-4380, weekdays, English and Spanish.

Clear filters Download all 7,816 as CSV

"Open to new participants" means the registry status is RECRUITING or NOT_YET_RECRUITING — 1,523 of the 7,816 records. That is what the sponsor last told the registry, which can be months out of date.
Location is by country. This pull of the registry records the countries a study runs in, not its individual sites, so we cannot filter by US state or city — and we are not going to guess one. To find the nearest site, open a trial's record below: the official page lists every location with its contact details.

Showing 7,651–7,675 of 7,816 matching trials · page 307 of 313, 25 per page.

Sorted by the date the registry record was last updated, newest first. This page never loads all 7,816 rows at once — use the CSV download if you want the whole file.

Registered Alzheimer's clinical trials. Every ID links to its official ClinicalTrials.gov record.
Trial Phase Status Enrolled Sponsor Last updated
Drug Interaction Study Between AZD3480 and Cytochrome P450
NCT00692510
AZD3480; Placebo; Cocktail mix (Caffeine, Bupropion, Rosiglitazone,...
Runs in: Sweden · 1 site 		PHASE1
other		 COMPLETED 18 AstraZeneca
INDUSTRY		 2008-11-26
Liquid Risperidone in the Treatment of Acute Agitation in Psychiatrically Hospitalized Children
NCT00790075
risperidone
Runs in: United States · 1 site 		PHASE4
other		 COMPLETED 24 Stony Brook University
OTHER		 2008-11-13
Drug Interaction Study With a Potential Alzheimer's Disease Compound
NCT00726726
Interacting drugs - Cooperstown Cocktail (midazolam, warfarin, (+ v...
Runs in: United States · 1 site 		PHASE1
other		 COMPLETED 22 Bristol-Myers Squibb
INDUSTRY		 2008-11-05
Safety of Three Formulations of Ketasyn Administered for 14 Days in Healthy Elderly
NCT00660088
Ketasyn
Runs in: United States · 1 site 		NA
other		 COMPLETED 60 Cerecin
INDUSTRY		 2008-10-08
A Study of Healthy Subjects to Assess the Effect of LY450139 on Amyloid Beta Peptide Production Rate and or Dose Response.
NCT00765115
LY450139; placebo
Runs in: United States · 1 site 		PHASE1
other		 COMPLETED 27 Eli Lilly and Company
INDUSTRY		 2008-10-02
Systematic Care for Informal Caregivers of Dementia Patients: An Efficient Approach?
NCT00147693
Diagnosis of caregivers' problems; Professional service: treatment ...
Runs in: Netherlands · 1 site 		NA
other		 COMPLETED 304 Radboud University Medical Center
OTHER		 2008-10-01
Study Evaluating Potential Pharmacokinetic (PK) Interaction Between Lecozotan and Digoxin
NCT00563732
Lecozotan 		PHASE1
other		 COMPLETED — Wyeth is now a wholly owned subsidiary of Pfizer
INDUSTRY		 2008-09-09
Amyotrophic Lateral Sclerosis and Frontotemporal Dementia
NCT00159198
Runs in: France · 15 sites 		NA
other		 TERMINATED 400 Assistance Publique - Hôpitaux de Paris
OTHER		 2008-09-08
Brain Imaging and Mental Disorders of Aging Intervention
NCT00267163
donepezil; Placebo
Runs in: United States · 1 site 		PHASE4
symptomatic-cholinergic		 COMPLETED 64 National Institute on Aging (NIA)
NIH		 2008-08-29
Tracking Technologies for the Analysis of Mobility in Alzheimer's Disease
NCT00743418
GPS modem and RFID
Runs in: Israel · 1 site 		PHASE1|PHASE2
other		 UNKNOWN 300 Tel-Aviv Sourasky Medical Center
OTHER_GOV		 2008-08-28
18-Month Study of the Efficacy of Xaliproden (SR57746A) in Patients With Mild-to-Moderate Dementia of the Alzheimer's Type
NCT00103649
xaliproden (SR57746A)
Runs in: Canada; United States · 121 sites 		PHASE3
other		 COMPLETED 1,306 Sanofi
INDUSTRY		 2008-08-21
Study of Xaliproden (SR57746A) in Patients With Mild-to-Moderate Dementia of the Alzheimer's Type
NCT00104013
xaliproden (SR57746A)
Runs in: Australia; France; Hong Kong; Italy; Netherlands; Singapo... · 41 sites 		PHASE3
other		 COMPLETED 1,455 Sanofi
INDUSTRY		 2008-08-21
European Study of HF0220 in Mild to Moderate Alzheimer's Disease Patients
NCT00357357
HF0220
Runs in: India; Sweden; United Kingdom · 10 sites 		PHASE2
other		 COMPLETED 40 Hunter-Fleming Ltd
INDUSTRY		 2008-08-21
Global Efficacy Study of MPC-7869 to Treat Patients With Alzheimer's
NCT00322036
MPC-7869; MPC-7869
Runs in: Belgium; Canada; Denmark; France; Germany; Italy; Netherl... · 92 sites 		PHASE3
other		 TERMINATED 800 Myrexis Inc.
INDUSTRY		 2008-08-05
Open-Label Treatment With MPC-7869 for Patients With Alzheimer's Who Previously Participated in an MPC-7869 Protocol
NCT00380276
MPC-7869
Runs in: Canada; United States · 90 sites 		PHASE3
other		 TERMINATED 1,000 Myrexis Inc.
INDUSTRY		 2008-08-05
Cognitive Effects of Aerobic Exercise for MCI Adults
NCT00220467
Aerobic exercise
Runs in: United States · 2 sites 		PHASE2
other		 COMPLETED 40 Seattle Institute for Biomedical and Clinical Research
OTHER		 2008-07-30
Study Evaluating GSI-953 in Healthy Young and Alzheimer's Patients
NCT00479219
GSI-953; Placebo
Runs in: United States · 1 site 		PHASE1
other		 COMPLETED 17 Wyeth is now a wholly owned subsidiary of Pfizer
INDUSTRY		 2008-07-10
Study Evaluating Safety, Tolerability, Pharmacokinetics and 5 HT1A Receptor Occupancy
NCT00499200
SRA-444
Runs in: Sweden · 1 site 		PHASE1
other		 COMPLETED 42 Wyeth is now a wholly owned subsidiary of Pfizer
INDUSTRY		 2008-07-09
Safety Study of CTS21166 to Treat Alzheimer Disease
NCT00621010
CTS21166 (ZPQ-21166)
Runs in: United States · 1 site 		PHASE1
other		 COMPLETED 56 CoMentis
INDUSTRY		 2008-07-09
Support Groups for Patients With Mild Cognitive Impairment and Their Partners
NCT00285753
support groups
Runs in: Netherlands · 2 sites 		PHASE2
other		 COMPLETED 110 Radboud University Medical Center
OTHER		 2008-05-21
Evaluation of [123I] AV83 and SPECT in Patients With Alzheimer Disease in Comparison to Healthy Controls
NCT00448799
[123-I] AV-83 Injection and Imaging Procedures
Runs in: United States · 1 site 		PHASE1
other		 COMPLETED 30 Molecular NeuroImaging
OTHER		 2008-05-13
Safety and Efficacy of MEM 1003 Versus Placebo in Patients With Mild to Moderate Alzheimer's Disease
NCT00257673
MEM 1003; MEM 1003; Placebo for MEM 1003
Runs in: United States · 57 sites 		PHASE2
other		 COMPLETED 183 Memory Pharmaceuticals
INDUSTRY		 2008-05-06
Safety and Efficacy of MEM 3454 Versus Placebo in Patients With Mild to Moderate Alzheimer's Disease
NCT00454870
MEM 3454
Runs in: United States · 7 sites 		PHASE2
other		 COMPLETED 80 Memory Pharmaceuticals
INDUSTRY		 2008-05-06
A Pilot Study of Curcumin and Ginkgo for Treating Alzheimer's Disease
NCT00164749
Placebo and ginkgo extract; Curcumin and ginkgo extract; Curcumin a...
Runs in: Hong Kong · 1 site 		PHASE1|PHASE2
other		 COMPLETED 36 Chinese University of Hong Kong
OTHER		 2008-04-30
Use of [123I] AV39 and SPECT Imaging as a Marker of Protein Disposition in Subjects With Alzheimer Disease Compared to Healthy Subjects
NCT00439010
[123I] AV 39
Runs in: United States · 1 site 		PHASE1
other		 COMPLETED 30 Molecular NeuroImaging
OTHER		 2008-04-24

This table is wider than a phone screen — swipe it sideways to see the rest.

Where these trials come from

Registry
ClinicalTrials.gov, pulled through their public API (v2)
Trials in the file
7,816
Source file
trials.csv (3.8 MB, 7816 rows)
Basis
Measured These are registry records as submitted by each study's sponsor.

What could make this misleading

Sponsors enter their own data and do not always keep it current, so "recruiting" can be out of date by months or years. Enrollment figures may be targets rather than actual numbers; the downloaded file says which for each trial. Trials that were never registered do not appear at all, and the intervention class is this project's own grouping, not the registry's.

Always check the official record before acting on anything here. This is a summary, not medical advice.

Related evidence Treatments → What the drugs that finished their trials actually achieved.

From the research library

The highest-scoring studies we hold on this subject, each summarised in plain English. Scores are alzhub's usefulness score, not a verdict on the science.

Clinical trials

All 162 studies on Clinical trials →